Hematology/Oncology

• In the Journals

• Alternative tumor staging system improved prognostic results for CSCC

• January 17, 2013
• An alternative tumor staging system offered improved prognostic discrimination via stratification of stage T2 cutaneous squamous cell carcinoma, according...More »

• In the Journals Perspective Video

• Smartphone apps varied in assessing melanomas

• HemOnc Today, March 10, 2013
• Smartphone applications varied greatly in accurately assessing melanoma risk, with the majority incorrectly classifying 30% of melanomas as benign and...More »

• In the Journals Perspective

• Sorafenib combined with carboplatin, paclitaxel failed to improve OS in advanced melanoma

• HemOnc Today, January 25, 2013
• The addition of sorafenib to carboplatin and paclitaxel did not improve OS among chemotherapy-naive patients with advanced melanoma, according to results...More »

• In the Journals

• Organ transplant recipients experienced cost factor for SCC

• January 7, 2013
• Squamous cell carcinoma, the most frequent cancer among organ transplant recipients, was a recurring cost factor for patients in a recent study.
  In a...More »

• In the Journals

• Pain significantly predicted SCC compared with BCC

• December 21, 2012
• Pain and itch were common symptoms of nonmelanoma skin cancer, with pain a significant predictor of squamous cell carcinoma, according to study results.
  In...More »

• Breakthroughs in T-cell physiology, new oral anticoagulants among highlights of 2012

• HemOnc Today, January 25, 2013
  Harry S. Jacob, MD, FRCPath(Hon); Joseph R. Bertino, MD
• Harry S. Jacob
  Joseph R. Bertino
  Each January of our 13-year tenure, we have attempted to spotlight particularly intriguing work reviewed in HemOnc Today...More »

• In the Journals

• Sentinel lymph node biopsy benefited cutaneous melanoma patients

• HemOnc Today, January 25, 2013
• Sentinel lymph node biopsy was accurate and reliable as a staging method in patients with cutaneous melanoma, according to study results.
  Researchers in...More »

• In the Journals

• Drug screening identified possible combination therapies for mutant BRAF, RAS melanomas

• HemOnc Today, January 25, 2013
• Researchers used combinatorial drug screening to identify potential treatment regimens, including statins and cyclin-dependent kinase inhibitors, for...More »

• In the Journals

• Researchers use genetics to refine model for assessing skin cancer risk

• December 11, 2012
• The risk for developing skin cancer involves numerous genetic factors, including family history or ancestry, based on a whole-genome prediction model...More »

• In the Journals

• Melanoma, nonmelanoma risk lower among vitiligo patients

• HemOnc Today, January 25, 2013
• Patients with vitiligo had a decreased risk for melanoma and nonmelanoma skin cancer, according to study results.
  In a retrospective mail-in survey,...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!